GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » 5-Year Dividend Growth Rate

Egyptian International Pharmaceutical Investments (CAI:PHAR) 5-Year Dividend Growth Rate : -11.10% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments 5-Year Dividend Growth Rate?

Egyptian International Pharmaceutical Investments's Dividends per Share for the three months ended in Dec. 2023 was E£0.00.

During the past 12 months, Egyptian International Pharmaceutical Investments's average Dividends Per Share Growth Rate was -33.40% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -21.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -11.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Egyptian International Pharmaceutical Investments was 44.30% per year. The lowest was -21.10% per year. And the median was 6.30% per year.

Egyptian International Pharmaceutical Investments's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Egyptian International Pharmaceutical Investments's Dividend Yield % is 3.68%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Egyptian International Pharmaceutical Investments's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egyptian International Pharmaceutical Investments's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Egyptian International Pharmaceutical Investments's 5-Year Dividend Growth Rate falls into.



Egyptian International Pharmaceutical Investments 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Egyptian International Pharmaceutical Investments  (CAI:PHAR) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Egyptian International Pharmaceutical Investments's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ 1.873
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Egyptian International Pharmaceutical Investments was 0.81. The lowest was 0.24. And the median was 0.58.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Egyptian International Pharmaceutical Investments Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
EGP 2.0002024-04-282024-04-290000-00-00Cash DividendannuallyEGP:EGP 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Egyptian International Pharmaceutical Investments's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=2/38.56
=5.19 %

Current Share Price is E£38.56.
Egyptian International Pharmaceutical Investments's Dividends per Share for the trailing twelve months (TTM) ended in Today is E£2.

During the past 13 years, the highest Dividend Yield of Egyptian International Pharmaceutical Investments was 10.68%. The lowest was 2.33%. And the median was 5.13%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Egyptian International Pharmaceutical Investments 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description

Traded in Other Exchanges
N/A
Address
1st Industrial Zone B1, EIPICO, 10th of Ramadan, EGY
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.

Egyptian International Pharmaceutical Investments (CAI:PHAR) Headlines